TY - JOUR
T1 - International perspectives on opioid use disorder and treatment
T2 - results from an online convenience sample
AU - Melby, Katherine
AU - Farokhnia, Mehdi
AU - Tolomeo, Serenella
AU - Bhad, Roshan
AU - Bramnes, Jørgen G
AU - Baldacchino, Alexander Mario
AU - Rao, Ravindra
AU - Kandasami, Gomathinayagam
AU - Butner, Jenna L
AU - Phan, Vicky
AU - Fonseca, Francina
AU - Rafei, Parnian
AU - Jiang, Long
AU - Georgios, Tzeferakos
AU - Dom, Geert
N1 - Funding: M.F. is an employee of the US Federal Government and is supported by National Institutes of Health (NIH) intramural funding (ZIA-DA000635 and ZIA-AA000218).
PY - 2023/8/20
Y1 - 2023/8/20
N2 - Opioid use disorder (OUD) is a chronic disease characterised by periods of abstinence and episodic return to use, that is associated with enormous socioeconomic burden and great risk for morbidity and mortality. Implementation of national opioid agonist treatment programs (OAT) has been an important strategy to respond to the opioid crisis tailored to each region. Heterogeneity across such programs and policies introduces a challenge in terms of harmonisation but also an opportunity for mutual learning and improvement. In this study, a convenience sample of 15 addiction medicine professionals were invited to complete an online questionnaire focused on challenges and strategies in delivering OAT in different countries and regions. Although national opioid treatment programs (OTP) were available in all but one country, important barriers were identified, and treatment coverage was overall low. In some countries, political and legislative changes are needed to improve public health responses and community attitudes towards persons with opioid use disorder (PWOUD). Providing evidence-based information to clinicians and individuals, strengthening the education of health professionals, and minimising stigma at different levels are seen as important steps that national and international institutions must take to address the opioid crisis
AB - Opioid use disorder (OUD) is a chronic disease characterised by periods of abstinence and episodic return to use, that is associated with enormous socioeconomic burden and great risk for morbidity and mortality. Implementation of national opioid agonist treatment programs (OAT) has been an important strategy to respond to the opioid crisis tailored to each region. Heterogeneity across such programs and policies introduces a challenge in terms of harmonisation but also an opportunity for mutual learning and improvement. In this study, a convenience sample of 15 addiction medicine professionals were invited to complete an online questionnaire focused on challenges and strategies in delivering OAT in different countries and regions. Although national opioid treatment programs (OTP) were available in all but one country, important barriers were identified, and treatment coverage was overall low. In some countries, political and legislative changes are needed to improve public health responses and community attitudes towards persons with opioid use disorder (PWOUD). Providing evidence-based information to clinicians and individuals, strengthening the education of health professionals, and minimising stigma at different levels are seen as important steps that national and international institutions must take to address the opioid crisis
KW - International perspective
KW - Opioid use disorder
KW - Opioid agonist treatment
UR - https://www.heroinaddictionrelatedclinicalproblems.org/harcp-archives.php?year=2023
M3 - Article
SN - 1592-1638
VL - Ahead of Print
JO - Heroin Addiction and Related Clinical Problems
JF - Heroin Addiction and Related Clinical Problems
ER -